Evidence map›Paper›PMID 32951180›Full record

ArticleInternational journal of clinical pharmacy2021

Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study.

Hélio Guedes, Manuel Morgado, Márcio Rodrigues, Agostinho Cruz, Cecília Fonseca, Elísio Costa, André R T S Araujo

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Knowledge and awareness of ocular allergy among Jeddah population.Journal of family medicine and primary care · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hélio GuedesSchool of Health Sciences, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-035, Guarda, Portugal.
Manuel MorgadoSchool of Health Sciences, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-035, Guarda, Portugal.
Márcio RodriguesSchool of Health Sciences, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-035, Guarda, Portugal.
Agostinho CruzSchool of Health Sciences, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072, Porto, Portugal.
Cecília FonsecaSchool of Health Sciences, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-035, Guarda, Portugal.
Elísio CostaREQUIMTE, Faculty of Pharmacy, Porto4Ageing, UCIBIO, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal.
André R T S AraujoSchool of Health Sciences, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-035, Guarda, Portugal. andrearaujo@ipg.pt.ORCID http://orcid.org/0000-0003-3510-948X
University of Beira Interior · PTUniversidade do Porto · PTInstituto Politécnico da Guarda · PTPolytechnic Institute of Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Allergic rhinitis represents a public health problem that is significantly prevalent in the global population and has been associated with asthma, a strong desire to sleep and a low quality of life. Objective This study aims to evaluate the prevalence, symptoms, control strategies and treatment, as well as the control of this condition and its impact on the quality of life of customers of community pharmacies with allergic rhinitis. Setting A questionnaire survey was carried out in nine community pharmacies in the city of Guarda, Portugal. Method In this cross-sectional study, data was collected by an interview between May 2014 and December 2014. The control of the illness and the impact of allergic rhinitis on the quality of life were assessed through a CARAT10 test and a WHOQOL-BREF instrument, respectively. Main outcome measure The impact of allergic rhinitis on the patient's quality of life. Results The estimated prevalence of allergic rhinitis was between 10.8% and 15.4%, from which 63 and 42 individuals were medically and symptomatically diagnosed, respectively, from a study population of 804 respondents. The majority of participants (57.1%) suffered from the symptoms more than twice a year. The symptoms, such as difficulty in falling asleep, repeated and continuous sneezing and bilateral nasal obstruction, were severe. There were patients with uncontrolled allergic rhinitis symptoms after the CARAT10 test, even when the individual's perception of the quality of life was good according to the WHOQOL-BREF score, with gender differences in the psychological domain. It should also be emphasized that there was a significant association between higher education levels with better control of the illness/quality of life. Additionally, most participants used pharmacological treatment (not alternative therapies) and the adoption of self-management measures to relieve their symptoms. Conclusions The findings of this study showed that the estimated prevalence of allergic rhinitis seems to be apparently lower in Guarda than that found in the general Portuguese population. From the data, some patients showed uncontrolled allergic rhinitis symptoms, strengthening the importance of the role of intervention by a health professional.

Indexed as

AsthmaPharmaciesRhinitis, AllergicCross-Sectional StudiesHumansQuality of LifeSurveys and QuestionnairesAllergic rhinitisCARAT10 testCommunity pharmacyGuardaQuality of lifeWHOQOL-BREF

Identifiers

PMID32951180
OpenAlexW3087465360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.